Radiotherapy-Associated Atrial Fibrillation

Radiotherapy associated Atrial Fibrillation (RADAF) is an observational study to evaluate onset time and frequency of atrial fibrillation in patients with thoracic malignancies and breast cancer.

Each patient will have 12 lead ECG prior, and daily during radiotherapy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atrial Fibrillation New Onset Arrhythmias, Cardiac Atrial Fibrillation Breast Diseases Breast Neoplasms Cardiotoxicity Cardiovascular Diseases Chemically-Induced Disorders Drug-Related Side Effects and Adverse Reactions Heart Diseases Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Pathologic Processes Pathological Conditions, Signs and Symptoms Radiation Injuries Respiratory Tract Diseases Respiratory Tract Neoplasms Skin Diseases Skin and Connective Tissue Diseases Thoracic Neoplasms Wounds and Injuries

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Istanbul Faculty of Medicine

Fatih, Istanbul, 34093, Turkey (Türkiye)

About this study

Collected data will be truly anonymised and individuals will no longer identifiable, and than evaluated for occurrence of atrial fibrillation.

Inclusing Criteria:

Patients with radiotherapy for thoracic malignancy or breast cancer
Between 18-99 years-old

Exclusion criteria

Patients with history of radiotherapy
Patients with history of atrial fibrillation
Patients with pacemaker implantation

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with radiotherapy for thoracic malignancy or breast cancer
Between 18-99 years-old

Exclusion criteria

Patients with history of radiotherapy
Patients with history of atrial fibrillation
Patients with pacemaker implantation

Treatment and study plan

ECG

Diagnostic Test

12 lead ecg for each participant

Primary outcomes

Occurrence of atrial fibrillation

Time frame: 1 day During radiotherapy

Occurrence of atrial fibrillation
Onset time of atrial fibrillation

Time frame: 1 day During radiotherapy

Onset time of atrial fibrillation

Sponsors and collaborators

Lead sponsor

Istanbul University

Other

Registry information

Official study title

Radiotherapy-associated Atrial Fibrillation: Onset Time and Frequency

Acronym: RADAF

Important dates

Study start: 2023
Primary completion: 2023
Study completion: 2023
First posted: Jul 3, 2023
Registry last updated: Jul 3, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed